Maxim Group upgraded Inovio Pharmaceuticals (NASDAQ: INO) from Hold to Buy with a price target of $10.00.Analyst Jason McCarthy highlighted:Inovio ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Upgrades

Piper Jaffray Downgrades Inovio Pharmaceuticals (INO) to NeutralMarch 16, 2017 2:53 AM Inovio Pharma (INO) Misses Q4 EPS by 5cMarch 15, 2017 4:06 PM Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial ResultsMarch 15, 2017 4:05 PM